Cargando…
Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast
BACKGROUND: Carcinoma-associated fibroblasts (CAFs) can promote carcinogenesis and tumor progression. Only limited data on the response of CAFs to chemotherapy and their potential impact on therapy outcome are available. This study was undertaken to analyze the influence of chemotherapy on carcinoma...
Autores principales: | Sonnenberg, Maike, van der Kuip, Heiko, Haubeiß, Silke, Fritz, Peter, Schroth, Werner, Friedel, Godehard, Simon, Wolfgang, Mürdter, Thomas E, Aulitzky, Walter E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626600/ https://www.ncbi.nlm.nih.gov/pubmed/19077243 http://dx.doi.org/10.1186/1471-2407-8-364 |
Ejemplares similares
-
Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts
por: Haubeiss, Silke, et al.
Publicado: (2010) -
Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment
por: van der Kuip, Heiko, et al.
Publicado: (2006) -
Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec(®), Gleevec™)
por: Henkes, Martin, et al.
Publicado: (2008) -
c-erbB2 and topoisomerase IIα protein expression independently predict poor survival in primary human breast cancer: a retrospective study
por: Fritz, Peter, et al.
Publicado: (2005) -
Monitoring the initial pulmonary absorption of two different beclomethasone dipropionate aerosols employing a human lung reperfusion model
por: Freiwald, Matthias, et al.
Publicado: (2005)